UNC Gillings School of Global Public Health, Chapel Hill, NC 27599, USA.
Am J Mens Health. 2011 Jul;5(4):297-305. doi: 10.1177/1557988310372802. Epub 2010 Aug 26.
We know little about men's beliefs about human papillomavirus (HPV) vaccine and willingness to receive it. In January 2009, the authors recruited 296 heterosexual men and 312 gay and bisexual men from a national panel of U.S. households to complete an online survey about HPV and HPV vaccine. The authors analyzed data using logistic regression, controlling for age, education, number of lifetime sexual partners, and urban residence. More gay and bisexual men than heterosexual men were willing to receive HPV vaccine (73% vs. 37%; adjusted odds ratio = 4.99; 95% confidence interval = 3.36, 7.49). Gay and bisexual men reported greater awareness of HPV vaccine, perceived worry about HPV-related diseases, perceived effectiveness of HPV vaccine, and anticipated regret if they declined vaccination and later developed HPV-related disease compared with heterosexual men (all ps < .05). The lower acceptability and different beliefs among heterosexual men suggest that novel interventions for this group may be needed.
我们对男性关于人乳头瘤病毒（HPV）疫苗的信念和接种意愿知之甚少。2009 年 1 月，作者从美国家庭的全国小组招募了 296 名异性恋男性和 312 名男同性恋和双性恋男性，以完成一项关于 HPV 和 HPV 疫苗的在线调查。作者使用逻辑回归分析数据，控制年龄、教育程度、终身性伴侣数量和城市居住情况。与异性恋男性相比，男同性恋和双性恋男性更愿意接种 HPV 疫苗（73%比 37%；调整后的优势比=4.99；95%置信区间=3.36，7.49）。男同性恋和双性恋男性报告称，他们对 HPV 疫苗的认识、对 HPV 相关疾病的担忧、对 HPV 疫苗有效性的预期以及如果他们拒绝接种疫苗，日后患上 HPV 相关疾病的预期遗憾程度，均高于异性恋男性（所有 p 值均<.05）。异性恋男性的接受程度较低和不同的信念表明，可能需要针对这一群体的新干预措施。
